Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acetylcholine
acetylcholine in CNS
adverse drug reaction
alpha methyldopa hydrazine
alpha methyltyrosine
Alzheimer's disease
amantadine
amitriptyline
amphetamines
anticholinergic drugs
anticholinergic drugs, side effects of
anticholinesterase
ataxia
ataxia, hereditary
atropine
benzodiazepine
bethanechol
brain biopsy
catecholamine
cerebellar atrophy, primary
choline acetyltransferase
choline chloride
cholinergic crisis
cholinergic drug
clonazepam
critical care unit
deanol
dopamine
dopamine antagonist
enzyme, defect
eye, pain in
Friedreich's ataxia
haloperidol
Huntington's chorea
imipramine
immunosuppressive agents
insecticides
lacrimation
L-dopa
L-dopa, drug interactions with and side effects of
L-dopa, potentiators of
lecithin
lithium
memory, defect of recent
memory, disorder, treatment of
memory, impairment of
mestinon
monoamine oxidase inhibitors
monoamines
monoamines, brain
mortality
muscle weakness
myasthenia gravis
myasthenia gravis, thymectomy in
myasthenia gravis, treatment of
myasthenic crisis
nausea and vomiting
neuroleptic
neurologic disease, diagnoses of
neurotoxin
neurotransmitter
occupational neurologic disorders
papaverine
Parkinson disease
Parkinson disease, drug induced
Parkinson disease, treatment of
Parkinsonism syndrome
parsidol
peptides, brain
phenothiazine
physostigmine
pilocarpine
pimozide
plasmapheresis
poison, neurologic problems with
poison, organophosphate
procyclidine
reserpine and reserpine like drugs
respiratory failure
ritalin
salivation, excessive
seizure
serotonin
spinocerebellar ataxia type 1
spinocerebellar degeneration
steroid therapy, CNS treatment and complications with
tardive dyskinesia
tardive dyskinesia, treatment of
tetrabenazine
thymectomy
toxins, nervous system
treatment of neurologic disorder
tricyclic antidepressant
weakness
Showing articles 0 to 50 of 6644 Next >>

Managing Acute Organophosphorus Pesticide Poisoning
BMJ 334:629-634, Roberts,D.M.&Aaron,C.K., 2007

Induction of Parkinsonism by Intraventricular Bethanechol in a Patient with Alzheimer's Disease
Neurol 39:1265, Fox,J.H.,et al, 1989

Neurochemical Studies of Early Onset Alzheimer's Disease, Possible Influence on Treatment
NEJM 313:7-11, Francis,P.T.,et al, 1985

Neurotransmitters & CNS Disease
Lancet 2:914-918, Iversen,L.L., 1982

Cholinomimetic Treatment Fails To Improve Memory Disorders
NEJM 303:585-586, 1980. (letter), Caine,E.D., 1980

Controversies About the Treatment of Myasthenia Gravis
JNNP 43:644-659, Rowland,L.P., 1980

Possible Biochemical Basis of Memory Disorder in Alzheimer Disease
Ann Neurol 3:471, Smith,C.M.,et al, 1978

Drug Therapy of Tardive Dyskinesia
NEJM 296:257, Kobayashi,R.M., 1977

Physostigmine in Familial Ataxias
Neurol 27:70, Kark,R.A.,et al, 1977

Drug Therapy of Parkinsonism
NEJM 287:20, Yahr,M.,et al, 1972

Acetylcholine-Current Status in Physiology, Pharmacology, & Medicine
NEJM 286:1086, Koelle,G., 1972

Cholinergic & Dopaminergic Mechanisms in Huntington's Chorea
Life Sciences 10:405 1971., Aquilonius,S.,et al, 1971

Addressing Systemic Complications of Acute Stroke: A Scientific Statement From the American Heart Association
Stroke 56:e15-e29, Kumar,S.,et al, 2025

Spectrum of Intracranial Hemorrhages in Cerebral Venous Thrombosis, A Pictorial Case Series and Review of Pathophysiology and Management
Neurologist 30:45-51, Jha,S.,et al, 2025

Angioedema Following Tenecteplase for Acute Ischemic Stroke
Stroke 55:e242-e244, Dellabella,A., 2024

Forensic Neurology:Practice Considerations and Training Opportunities
Neurol 103:e209560, Zheng,D.,et al, 2024

Clinicopathologic Conference, Brain Abscess Due to Infection with Listeria Monocytogeneses
NEJM 391:1529-1538, Case 33-2024, 2024

Acute Postradiation Lumbosacral Plexopathy
Neurol 103:e209972, Koropouli,E.,et al, 2024

Cerebrovascular Events in Patients Undergoing Transcatheter Aortic Valve Replacement:A Review
Stroke 55:2754-2764, Patel,K.P.,et al, 2024

Optimal Timing of Anticoagulation after Acute Ischaemic Stroke with Atrial Fibrillation (OPTIMAS): A Multicentre, Blinded-Endpoint, Phase 4, Randomised Controlled Trial
Lancet 404:1731-1741, Werring,D.J.,et al, 2024

Intramedullary Spinal Cord Abscess Caused by Acupuncture
Ann Neurol 96:1026-1027, Liu,J.,et al, 2024

Clinical Features, Diagnosis and Management of Klinefelter Syndrome
www.UptoDaate.com, Matsumoto,A.M. & Anawals,B.D., 2024

Middle Meningeal Artery Embolisation for Nonacute Subdural Hematoma
NEJM 391:1901-1912, Ni,J.L.W.,et al, 2024

Adjunctive Middle Meningeal Artery Embolization for Subdural Hematoma
NEJM 391:1890-1900, Davies,J.M.,et al, 2024

Chronic Immunotherapy for Myasthenia Gravis
www.UptoDate.Com, Bird,S.J., 2024

Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine, A Phase 4, Randomized, Placebo-Controlled Trial
JAMA Neurol 81:1140-1149, Tepper,S.J.,et al, 2024

Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation
JAMA Neurol 81:1150-1158, Maarse,M.,et al, 2024

How Patients Are Using AI
BMJ 387:q2393, Stokel-Walker,C., 2024

2024 Guide for the Primary Prevention of Stroke:A Guideline From the American Heart Association/American Stroke Association
Stroke 55:e344-e424, Bushnell,C.,et al, 2024

Tranexamic Acid Within 4.5 Hours of Intracerebral Hemorrhage With the CTA Spot Sign, Systematic Review and Individual Patient Meta-Analysis
Neurol 103:e210104, Yassi,N.,et al, 2024

Safety and Efficacy of Staged, Bilateral Focused Ultrasound Thalamotomy in Essential Tremor, An Open-Label Clinical Trial
JAMA Neurol 81:939-946, Kaplitt,M.G.,et al, 2024

Miyazaki Syndrome as a Complication of Shunt Drainage
Ann Neurol 96:1230-1231, vanLanen,R.H.G.J., et al, 2024

Clinicopathologic Conference, Cryptococcal Meningoencephalitis
NEJM 391:2361-2369, Case 40-2024, 2024

Effect of IV Thrombolysis With Alteplase in Patients with Vessel Occlusion in the WAKE-UP Trial
Neurol 104:e209871, Galinovic,I.,et al, 2024

Association of Assisted Reproductive Technology and Stroke During Hospitalization for Delivery in the United States
Stroke 55:999-1005, Dicpinigaitis,A.J.,et al, 2024

Transcarotid Arter Revascularization Expanding Our Arsenal for the Management of Symptomatic Carotid Artery Stenosis
Stroke 55:931-933, Palaiodimou,L, 2024

Rabbit Syndrome
Neurol102:e209275, Huynh,T.U., & Beckley, E.H., 2024

Posttransplant Anti-GABAA Receptor Antibody-Associated Autoimmune Encephalitis
Neurol 102:e209245, Togni,C.L.,et al, 2024

Anti-NMDA Receptor Encephalitis Presenting with Cerebellitis in a Pediatric Patient
Neurol 102:e209259, Moehlman,M. & Kornbluh,A.B., 2024

Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage
JAMA Neurol 8:363-372, Sheth,K.M.,et al, 2024

Immunosuppressive Therapy Reversing Obstructive Hydrocephalus in CLIPPERS
Neurol 102:e209396, Yang,Y.,et al, 2024

Uncommon Causes of Nontraumatic Intracerebral Hemorrhage
Stroke 55:1416-1427, Tartarin,H.,et al, 2024

Treatment Modalities and Outcomes in Brainstem Cavernous Malformations: A Large Multicenter Observational Cohort Study
Stroke 55:1151-1160, Lu,J.,et al, 2024

Herpes Simplex Virus Encephalitis in Patients with Autoimmune Conditions or Exposure to Immunomodulatory Medications
Neurol 102:e209297, Tang,A.,et al, 2024

Trial of Thrombectomy for Stroke with a Large Infarct of Unrestricted Size
NEJM 390:1677-1689, Costalat,V.,et al, 2024

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
NEJM 390:1745-1755, 1815, Connolly,S.J.,et al, 2024

Mechanical Thrombectomy in Anticoagulated Patients with Acute Ischemic Stroke, A Meta-Analysis
Neurologist 29:194-203, Zhang,H.L.,et al, 2024

Tenecteplase Versus Standard of Care for Minor Ischaemic Stroke with Proven Occlusion (TEMPO-2): A Randomised, Open Label, Phase 3 Superiority Trial
Lancet 403:2597-2605, Coutts,S.B.,et al, 2024

Leptomeningitis with Communicating Hydrocephalus in an Immunocompromised Patient with Disseminated Sporotrichosis
Neurol 103:e209586, Taborda,M.H.,et al, 2024



Showing articles 0 to 50 of 6644 Next >>